White label – Pompe disease - ClinicalTrials.eu

Long-term safety study of Temferon (modified stem cells with interferon-α2) in patients previously treated for glioblastoma multiforme

Recruiting

1 1 1
Investigated Diseases:
- Glioblastoma multiforme
Investigated Drugs:
- Autologous Cd34+ Haematopoietic Stem And Progenitor Cells Transduced With A Lentiviral Vector Encoding The Interferon Alpha-2 Gene
Study on F-18 PSMA-11 PET Imaging for Liver Cancer in Patients to Evaluate Survival

Recruiting

2 1 1
Investigated Drugs:
- Gozetotide Alf-18
Study on Antibiotic Prophylaxis with Piperacillin, Tazobactam, and Cefazolin for Burn Patients Undergoing Excision-Graft Surgery

Recruiting

3 1 1
Investigated Diseases:
- Thermal burn
Investigated Drugs:
Study on Clemastine and Aerobic Exercise for Improving Cognitive Function in Schizophrenia Patients

Recruiting

2 1 1
Investigated Diseases:
- Schizophrenia
Investigated Drugs:
- Clemastine
- Placebo
Study on Crizotinib for Treating Severe Neurofibromatosis Type 2 in Children Not Eligible for Surgery or Radiotherapy

Recruiting

2 1 1 1
Investigated Diseases:
- Neurofibromatosis
Investigated Drugs:
- Crizotinib
Study of Risedronate Sodium for Patients with Dilated Cardiomyopathy Due to Troponin T Gene Mutation

Recruiting

2 1 1 1
Investigated Diseases:
- Dilated cardiomyopathy
Investigated Drugs:
- Risedronate Sodium
Study of Gilteritinib, Venetoclax, and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutations Not Eligible for Intensive Treatment

Recruiting

2 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
Study on the Use of Fludeoxyglucose (18F) in PET/CT Scans for Young Patients with Histiocytosis

Recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- Fludeoxyglucose (18F)
Study on the Effectiveness of Pembrolizumab and Ipilimumab in Melanoma Patients with Brain Metastases Requiring Steroid Treatment

Recruiting

2 1 1 1
Investigated Diseases:
- Malignant melanoma
Investigated Drugs:
Study of Tislelizumab immunotherapy in patients with liver cancer (hepatocellular carcinoma) who have moderately impaired liver function (Child-Pugh B)

Recruiting

2 1 1 1
Investigated Diseases:
- Hepatocellular carcinoma
Investigated Drugs:
- Tislelizumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies